Positive; ADT increases the abundance of CD68+ macrophages. This elevated relative abundance of CD68+ cells favored prostate cancer progression and recurrence in control group. No correlations with clinical parameters or recurrence were observed in the ADT group. This evidence concerns the gene CD68 and prostate cancer.